About
OurCrowd is a global venture investing platform that empowers institutions and individuals to invest and engage in emerging companies. The most active venture investor in Israel, OurCrowd vets and selects companies, invests its capital, and provides its global network with unparalleled access to co-invest and contribute connections, talent and deal flow. OurCrowd builds value for its portfolio companies throughout their lifecycles, providing mentorship, recruiting industry advisors, navigating follow-on rounds and creating growth opportunities through its network of multinational partnerships.
Key facts
- Website
- ourcrowd.com
- Type
- Crowdfunding
- Headquarters
- Jerusalem, Israel
- Funds raised
- $60M
- Portfolio companies
- 213
- Stages
- Pre-SeedSeedSeries ASeries BSeries C
- Cheque size
- $900K to $300M
- Sector focus
- HealthcareCybersecurityEndpoint SecurityComputed Tomography (CT)Magnetic Resonance Imaging (MRI)
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 16 Oct 2025 | Omnix Medical | Series C | $25M |
| 4 Aug 2025 | AIxBlock | Grant | $2M |
| 4 Oct 2024 | Kando | Series C | $10M |
| 30 Jul 2024 | Blue Tree Technologies | Seed | $2M |
| 25 Jul 2024 | Scopio Labs | Series D | $42M |
| 24 Jul 2024 | Scopio Labs | Undisclosed round | $10M |
| 17 Jul 2024 | CytoReason | Series B | $80M |
| 9 Apr 2024 | Carrar | Series A | $5M |
| 19 Mar 2024 | NeuReality | Series A2 | $20M |
| 6 Feb 2024 | Bionaut Labs | Series B | $9M |
OurCrowd scores 67. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
What companies has OurCrowd invested in?
OurCrowd has invested in Omnix Medical, AIxBlock, Kando, Blue Tree Technologies, Scopio Labs and 208 more.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for OurCrowd
